Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 AUD | +2.94% | +7.69% | +218.18% |
Apr. 30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
Apr. 18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+218.18% | 8.15M | |
+34.35% | 705B | |
+31.04% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.77% | 238B | |
-3.60% | 210B | |
+10.04% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- NYR Stock
- News Nyrada Inc.
- Nyrada Secures AU$3.5 Million R&D Tax Rebate for Fiscal Year 2023; Shares Surge 30%